￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Sparsentan (sparsentan) has been officially approved by the European Union for the treatment of adult patients with IgA nephropathy

2026-02-01 22:25:32

Check Details
New immunotherapy Tarlatamab approved in Japan for treatment of refractory small cell lung cancer

2026-02-01 22:25:32

Check Details
Tucatinib/tucatinib combination shows meaningful activity in HER2+ metastatic breast cancer

2026-02-01 22:25:32

Check Details
Is the official price of Apelvis-Piqray in India cheap?

2026-02-01 22:25:32

Check Details
The main functions and indications of fotantinib/fotantinib

2026-02-01 22:25:32

Check Details
To explore the comparison of cabozantinib/nivolumab and lenvatinib/pembrolizumab in first-line advanced renal cancer

2026-02-01 22:25:32

Check Details
How Felinetan advances non-hormonal treatments for hot flashes

2026-02-01 22:25:32

Check Details
Combination of azatilizumab, ruxolitinib, and besudil causes reactions in chronic GVHD

2026-02-01 22:25:32

Check Details
First real-world study finds brivaracetam extended-release (SR) safe and effective for focal epileptic seizures

2026-02-01 22:25:32

Check Details
What is the latest price of a box of obeticholic acid in 2025?

2026-02-01 22:25:32

Check Details
FDA approves neratinib/neratinib as an orphan drug for the treatment of breast cancer-related brain metastases

2026-02-01 22:25:32

Check Details
Study shows bedaquiline monotherapy may improve skin lesions in patients with multibacillary leprosy

2026-02-01 22:25:32

Check Details
Category
相关知识